A previous in vivo study showed that apigenin‐mediated reduction of Glut‐1 and inactivation of the PI3K/Akt pathway contributed to radiosensitivity in laryngeal carcinoma.21 The gene discussed is SLC2A1; the disease is laryngeal carcinoma.